Best Practice Database Supports Bio-Pharma Product Launch
A series of six case study analogs recently published to the databasereview various aspects of product launch, providing unique perspectives forunderstanding the strategies and tactics utilized by top bio-pharma companiesto address commercial issues surrounding their products. One study, "FlomaxCase Study: Evolving Disease State Awareness to Succeed with New Method ofAction," reviews the strategy and tactics utilized by Boehringer-Ingelheim forthe BPH (Benign Prostatic Hyperplasia) indicated product, Flomax/Tamsulosin,to differentiate the product and to boost disease awareness to expand theproduct market. By carving out a niche as a BPH-specific drug and motivating alarge untapped patient pool through multiple communication tactics, Flomaxachieved blockbuster status. Executives and managers can use this research togain insights into methods for differentiating a product and creatingeffective communication tactics to boost awareness and sales of a new product.
For a complimentary summary from this case study, found in the BestPractice Database, "Flomax Case Study: Evolving Disease State Awareness toSucceed with New Method of Action," click on the following link:http://www3.best-in-class.com/dr330.htm.
For more information on this study or the Best Practice Database, contactRobert Naylor at firstname.lastname@example.org or (919) 767-9244. Interestedparties may sign-up for a customized tour of the database via the followingURL: http://www3.best-in-class.com/dw212.htm.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC, conducts work based on the simple yet profoundprinciple that organizations can chart a course to superior economicperformance by studying the best business practices, operating tactics andwinning strategies of world-class companies. For more than 15 years, ourhighly credentialed research staff has conducted primary research exclusivelyfor our Fortune 500 client base.Key topic areas in the research include: -- Market Entry Strategy -- Using Science to Differentiate -- Using Safety and Cost for Product Positioning -- Disease Awareness -- Physician Communications -- Patient Communications -- Overall Market Outreach -- Potential Market-Entry Strategies for New Products Metrics included in this report are: -- Lifecycle Timeline -- BPH Product Sales 1998-2006 -- BPH Market Leader Sales 1998-2006 -- Flomax DTC Spending 1999-2006
SOURCE Best Practices, LLC
You May Also Like